Inhibitor butaselen demonstrates cancer cell apoptosis in lung cancer, suggesting a new treatment strategy.
The TrxR/Trx inhibitor butaselen suppresses lung cancer by triggering ROS-induced apoptosis. This study provides a novel and effective regimen for treating lung cancer.
No takes yet. Share an insight, caveat, or question.
Yifan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: